Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1Endocrine 1

Conditions

Tongue Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Neoplasm Metastasis 1Head and Neck Neoplasms 1Gliosarcoma 1Glioblastoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Medullary 1Adenocarcinoma, Follicular 1

Interventions

vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1nintedanib 1mercaptoundecahydrododecaborate 1Surveys and Questionnaires 1Docetaxel 14-boronophenylalanine-fructose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Thyroid Neoplasms × mercaptoundecahydrododecaborate × Clear all
NCT00062348 2012-01-20

Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Completed
27 enrolled
EndocrineGastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Colonic Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Tongue Neoplasms, Colorectal Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡